The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity -: Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor γ and IκB kinase activities

被引:337
作者
Makowski, L
Brittingham, KC
Reynolds, JM
Suttles, J
Hotamisligil, GKS
机构
[1] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.M413788200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fatty acid-binding proteins are cytosolic fatty acid chaperones, and the adipocyte isoform, aP2, plays an important role in obesity and glucose metabolism. Recently, this protein has been detected in macrophages where it strongly contributes to the development of atherosclerosis. Here, we investigated the role of aP2 in macrophage biology and the molecular mechanisms underlying its actions. We demonstrate that aP2-deficient macrophages display defects in cholesterol accumulation and alterations in pro-inflammatory responsiveness. Deficiency of aP2 alters the lipid composition in macrophages and enhances peroxisome proliferator-activated receptor gamma activity, leading to elevated CD36 expression and enhanced uptake of modified low density lipoprotein. The increased peroxisome proliferator-activated receptor gamma activity in aP2-deficient macrophages is also accompanied by a significant stimulation of the liver X receptor alpha-ATP-binding cassette transporter A1-mediated cholesterol efflux pathway. In parallel, aP2-deficient macrophages display reduced I kappa B kinase and NF-kappa B activity, resulting in suppression of inflammatory function including reduced cyclooxygenase-2 and inducible nitric-oxide synthase expression and impaired production of inflammatory cytokines. Our results demonstrate that aP2 regulates two central molecular pathways to coordinate macrophage cholesterol trafficking and inflammatory activity.
引用
收藏
页码:12888 / 12895
页数:8
相关论文
共 49 条
[1]   Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux [J].
Akiyama, TE ;
Sakai, S ;
Lambert, G ;
Nicol, CJ ;
Matsusue, K ;
Pimprale, S ;
Lee, YH ;
Ricote, M ;
Glass, CK ;
Brewer, HB ;
Gonzalez, FJ .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (08) :2607-2619
[2]  
Baccam M, 1999, EUR J IMMUNOL, V29, P3855, DOI 10.1002/(SICI)1521-4141(199912)29:12<3855::AID-IMMU3855>3.0.CO
[3]  
2-S
[4]   Role of the peroxisome proliferator-activated receptor-γ (PPAR-γ) and its natural ligand 15-deoxy-Δ12,14-prostaglandin J2 in the regulation of microglial functions [J].
Bernardo, A ;
Levi, G ;
Minghetti, L .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (07) :2215-2223
[5]   SELECTIVE IMMORTALIZATION OF MURINE MACROPHAGES FROM FRESH BONE-MARROW BY A RAF/MYC RECOMBINANT MURINE RETROVIRUS [J].
BLASI, E ;
MATHIESON, BJ ;
VARESIO, L ;
CLEVELAND, JL ;
BORCHERT, PA ;
RAPP, UR .
NATURE, 1985, 318 (6047) :667-670
[6]   Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia [J].
Boord, JB ;
Maeda, K ;
Makowski, L ;
Babaev, VR ;
Fazio, S ;
Linton, MF ;
Hotamisligil, GS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (10) :1686-1691
[7]   A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis [J].
Chawla, A ;
Boisvert, WA ;
Lee, CH ;
Laffitte, BA ;
Barak, Y ;
Joseph, SB ;
Liao, D ;
Nagy, L ;
Edwards, PA ;
Curtiss, LK ;
Evans, RM ;
Tontonoz, P .
MOLECULAR CELL, 2001, 7 (01) :161-171
[8]   PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation [J].
Chawla, A ;
Barak, Y ;
Nagy, L ;
Liao, D ;
Tontonoz, P ;
Evans, RM .
NATURE MEDICINE, 2001, 7 (01) :48-52
[9]  
Chen SY, 2001, SPECTROSC SPECT ANAL, V21, P377
[10]   PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway [J].
Chinetti, G ;
Lestavel, S ;
Bocher, V ;
Remaley, AT ;
Neve, B ;
Torra, IP ;
Teissier, E ;
Minnich, A ;
Jaye, M ;
Duverger, N ;
Brewer, HB ;
Fruchart, JC ;
Clavey, V ;
Staels, B .
NATURE MEDICINE, 2001, 7 (01) :53-58